Midlands Innovation Immunology Network (MIIN) is a joint partnership across the 7 Midlands Innovation Health institutions which aims to:
- Encourage research collaboration and stimulating the building of new collaborative research, innovation and training opportunities.
- Promote the development of high-quality collaborative proposals from the Midlands Innovation partnership utilising our assets and ensuring the region is attracting the necessary state-of-the-art research facilities and staff to the region.
- Ensure that Midlands Immunology Network is perceived as one of the leading groups promoting research, sharing of equipment and training.
- Support activities that raise the profile of the Midlands Immunology Network collaboration regionally and nationally.
- Enable the Midlands to respond appropriately to government and research funder policy and ambitions.
- Build strong relationships with key stakeholders in government, with funding councils and with local and regional stakeholders.
- Create the environment for a growth in collaborations between the Midlands Innovation partners.
■ Aston University: Dr Ewan Ross
■ University of Birmingham: Dr David Bending
■ Keele University: Dr Ella Maysami
■ University of Leicester: Professor Dave Cousins
■ Loughborough University: Professor Lettie Bishop
■ University of Nottingham: Professor Lucy Fairclough (CHAIR)
■ University of Warwick: Professor Lawrence Young
MIIN is currently running a series of Midlands Showcase events. For more information and to watch previous events click here
| Midlands Strengths and Capabilities Catalogue | |
| Biology | |
| Extracellular Vesicles | Nottingham, Aston, Birmingham and Loughborough |
| Dendritic cells – including lectin receptors | Nottingham |
| Macrophages and Innate immunity | Nottingham and Keele |
| B cells and antibodies – including monoclonal | Nottingham and Birmingham |
| T cells – including Inducible Treg | Nottingham, Loughborough, Birmingham and Leicester |
| Bacterial pathogenesis | Nottingham and Leicester |
| NK/innate lymphoid cells | Loughborough and Leicester |
| Mucosal immunity | Loughborough |
| Interferons and interleukins | Nottingham |
| Myeloid cells | Birmingham |
| Applications | |
| Autoimmune diseases / Immunotherapy | Birmingham and Keele |
| Inflammation, auto inflammatory diseases, allergy and allergic sensitisation | Nottingham, Birmingham, Loughborough and Keele |
| COVID-19 biology (and related e.g. MERS-CoV), serology and immunophenotyping | Nottingham and Birmingham |
| COVID-19 treatment and vaccinations | Nottingham and Birmingham |
| Neuroimmunology and Neuroinflammation | Keele |
| Infectious disease (e.g. malaria) | Keele |
| Lung disease, respiratory infections and COPD | Nottingham, Birmingham and Leicester |
| Smoking and E-Cigarettes | Nottingham |
| Cancer – including Tumour models, immunotherapy, paediatrics and cancer vaccines | Nottingham, Birmingham, Keele and Loughborough |
| Mouse models | Nottingham |
| Liver Immunology and GI disease | Birmingham |
| Digital pathology | Birmingham and Warwick |
| Transplant Immunology and Immunoregulation | Birmingham |
| Exercise and physical activity | Loughborough |
| Regenerative responses and biomaterials | Aston, Loughborough, Nottingham and Keele |
| AMR, disinfectants and coatings | Birmingham |
| Ageing immune system | Aston and Birmingham |
| Next generation reverse vaccinology | Keele and Birmingham |
| Drug discovery | Keele |
| Core laboratory techniques | Nottingham and Birmingham (link to Flow Cytometry) |
